Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Dr Pepper Snapple Group, Inc.
Dr Pepper Snapple Group Does Not Endorse Mini-Tender Offer
July 20th, 2008
Dr Pepper Snapple Group, Inc. (NYSE:DPS) announced that it has been notified of an unsolicited "mini-tender offer" by TRC Capital Corporation to purchase up to 4,000,000 shares of DPS' common stock, representing approximately 1.58 percent of DPS' outstanding shares. TRC Capital's offer price of $20.00 represents a 4.67 percent discount to the closing price of DPS' stock on June 30, 2008 ($20.98), the day prior to the date of the offer. DPS does not recommend or endorse TRC Capital's unsolicited mini-tender offer. Mini-tender offers such as this one avoid many of the investor protections afforded for larger tender offers, including the filing of disclosure and other...
Source: Pharma Investments, Ventures & Law Weekly (2008-07-20)
|
